跳至主要内容
临床试验/ACTRN12621001123831
ACTRN12621001123831已完成未知

A feasibility trial evaluating the safety, acceptability and feasibility of a novel multi-component model of care for youth with Bipolar Disorder I or II.

Orygen0 个研究点目标入组 21 人开始时间: 2021年8月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
21

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
15 Years 至 25 Years(—)
性别
All

入选标准

  • 1. Age 15 to 25 years
  • 2. Diagnosis of BD I or II
  • 3. Ability to provide informed consent and/or have a parent or guardian provide consent
  • on their behalf.
  • 4. Ability and willingness to nominate an emergency contact person, such as a close
  • family member

排除标准

  • 1.Has previously received 6-months of care through a tertiary mental health service or a multi-disciplinary team for bipolar disorder or psychosis.
  • 2.Currently requiring tertiary mental health intervention or likely to require tertiary intervention in the next 6 months, due to high level of severity, complexity or risk.
  • 3.Experiencing psychosis or manic episode
  • 4.Intellectual disability that interferes with the likelihood of the participant receiving benefit from participation as judged by the treating clinician;
  • 5.Inability to converse in, or read English. English does not have to be the young person’s primary language; Does not have access to the internet and an internet-enabled device;
  • 6.High degree of hostility and impulsivity, as judged by the treating clinician, resulting in the clinician believing that inclusion in the research project may result in harm to the young person or other users (i.e. through interactions in the social network).
  • *Those experiencing a hypomanic episode will be treated, and upon remission, can be admitted to the study.

研究者

发起方
Orygen

相似试验